This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Find out which cash back credit cards have no annual fee to suit your spending habits. Discover the perfect card for you today!
27,937 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Oracle rides a rebound in AI spending with a hefty backlog and cloud growth; a 12-month target suggests meaningful up...
Investors weigh a fresh entry point for ServiceNow as the stock resets after sector-wide multiple compression. Analys...
As AI reshapes enterprise tech, investors wonder if CrowdStrike can translate vigilance into lasting outsized returns...
Investors are buzzing about what happening with quantumscape. This article breaks down the core catalysts, risks, and...
A major strategic bet on U.S. manufacturing, taiwan semiconductor commits investing another $100B in the United State...
ServiceNow faces AI disruption head-on, arguing its execution platform creates a durable moat even as shares slide. C...
A hidden Medicare surcharge tied to income can lift monthly costs by hundreds for pre-retirees. Here’s how IRMAA work...
In May 2026, a Cohu director disclosed a sizable open-market sale. This article breaks down the numbers, explains For...
A couple nearing retirement with $1.6 million in pre-tax 401K assets weighs a Roth conversion path to reduce taxes an...
Tech’s latest earnings show Big Tech leaning into AI infrastructure, pushing capital spending higher as data centers ...
A shocking on-stage moment can ripple through a performer's finances. This article breaks down how reportedly used fa...